[HTML][HTML] Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors
Background Retinal vein occlusion (RVO) is the second most common retinal vascular
disorder that affected 16.4 million people worldwide in 2008. The last decade has seen new …
disorder that affected 16.4 million people worldwide in 2008. The last decade has seen new …
Vascular endothelial growth factor a in intraocular vascular disease
The vascular beds supplying the retina may sustain injury as a result of underlying disease
such as diabetes, and/or the interaction of genetic predisposition, environmental insults, and …
such as diabetes, and/or the interaction of genetic predisposition, environmental insults, and …
Natural history of branch retinal vein occlusion: an evidence-based systematic review
SL Rogers, RL McIntosh, L Lim, P Mitchell, N Cheung… - Ophthalmology, 2010 - Elsevier
OBJECTIVE: To describe the natural history of branch retinal vein occlusion (BRVO) based
on the best available evidence from the literature. CLINICAL RELEVANCE: Branch retinal …
on the best available evidence from the literature. CLINICAL RELEVANCE: Branch retinal …
Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study
JF Korobelnik, FG Holz, J Roider, Y Ogura, C Simader… - Ophthalmology, 2014 - Elsevier
Purpose To evaluate the efficacy and safety of intravitreal aflibercept injections for treatment
of macular edema secondary to central retinal vein occlusion (CRVO). Design A …
of macular edema secondary to central retinal vein occlusion (CRVO). Design A …
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study
Purpose To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) for the
treatment of macular edema secondary to central retinal vein occlusion (CRVO). Design …
treatment of macular edema secondary to central retinal vein occlusion (CRVO). Design …
The burden of disease of retinal vein occlusion: review of the literature
M Laouri, E Chen, M Looman, M Gallagher - Eye, 2011 - nature.com
Retinal vein occlusion (RVO) is the second most common cause of vision loss due to retinal
vascular disease. A literature review was undertaken to understand the epidemiology …
vascular disease. A literature review was undertaken to understand the epidemiology …
Retinal-vein occlusion
TY Wong, IU Scott - New England Journal of Medicine, 2010 - Mass Medical Soc
Retinal-Vein Occlusion | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study
FG Holz, J Roider, Y Ogura, JF Korobelnik… - British Journal of …, 2013 - bjo.bmj.com
Aim To evaluate intravitreal VEGF Trap-Eye (VTE) in patients with macular oedema
secondary to central retinal vein occlusion (CRVO). Methods In this double-masked study …
secondary to central retinal vein occlusion (CRVO). Methods In this double-masked study …
[HTML][HTML] Retinal capillary network and foveal avascular zone in eyes with vein occlusion and fellow eyes analyzed with optical coherence tomography angiography
M Adhi, MA Bonini Filho, RN Louzada… - … & visual science, 2016 - tvst.arvojournals.org
Purpose: To evaluate the perifoveolar retinal capillary network at different depths and to
quantify the foveal avascular zone (FAZ) in eyes with retinal vein occlusion (RVO) compared …
quantify the foveal avascular zone (FAZ) in eyes with retinal vein occlusion (RVO) compared …
[HTML][HTML] Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings
SS Park, G Bauer, M Abedi, S Pontow… - … & visual science, 2015 - jov.arvojournals.org
Purpose.: Because human bone marrow (BM) CD34+ stem cells home into damaged tissue
and may play an important role in tissue repair, this pilot clinical trial explored the safety and …
and may play an important role in tissue repair, this pilot clinical trial explored the safety and …